TRANSFORMED SMALL CELL LUNG CANCER
Clinical trials for TRANSFORMED SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for TRANSFORMED SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study tests a new medicine called PF-08634404 given with chemotherapy for adults with transformed small cell lung cancer (T-SCLC), a rare and aggressive cancer that develops from another lung cancer type. About 40 participants will receive the drug combo through IV infusions…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Experimental combo targets tough lung cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two drugs, lurbinectedin and osimertinib, is safe and effective for a rare type of lung cancer called transformed small cell lung cancer. The study will enroll 16 adults whose cancer has changed from a common form to this more a…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC